• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

Introduction to Tert-Butyl 3-Hydroxy-6-azabicyclo3.2.1octane-6-carboxylate (CAS No. 1824023-63-3)

Tert-Butyl 3-Hydroxy-6-azabicyclo3.2.1octane-6-carboxylate (CAS No. 1824023-63-3) is a sophisticated organic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, characterized by its intricate bicyclic structure and functional groups, presents a unique set of properties that make it valuable for various applications, particularly in drug development and molecular chemistry.

The molecular structure of Tert-Butyl 3-Hydroxy-6-azabicyclo3.2.1octane-6-carboxylate consists of a bicyclic framework with a tertiary butyl group and a hydroxyl group at strategic positions. This arrangement contributes to its stability and reactivity, making it a versatile intermediate in synthetic chemistry. The presence of an azabicyclo moiety further enhances its potential as a building block for more complex molecules.

In recent years, there has been growing interest in the use of such bicyclic compounds in medicinal chemistry due to their ability to mimic natural products and exhibit favorable pharmacokinetic properties. The< strong> Tert-butyl group, in particular, is known for its steric bulk, which can influence the binding affinity of drug candidates to biological targets. This feature is particularly useful in the design of enzyme inhibitors and receptor modulators.

One of the most compelling aspects of Tert-butyl 3-Hydroxy-6-azabicyclo3.2.1octane-6-carboxylate is its potential as a scaffold for the development of novel therapeutic agents. Researchers have been exploring its utility in the synthesis of compounds with anti-inflammatory, anti-cancer, and antimicrobial properties. The hydroxyl group provides a site for further functionalization, allowing chemists to tailor the molecule to specific biological targets.

Recent studies have highlighted the importance of azabicyclo compounds in drug discovery. These molecules often exhibit high selectivity and low toxicity, making them attractive candidates for clinical development. The< strong>bicyclo3.2.1octane core is particularly interesting because it can be modified to create diverse pharmacophores without compromising overall structural integrity.

The synthesis of Tert-butyl 3-Hydroxy-6-azabicyclo3.2.1octane-6-carboxylate involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advanced synthetic techniques, such as transition metal-catalyzed reactions and asymmetric synthesis, have been employed to enhance the efficiency of these processes. The ability to produce this compound in scalable quantities is crucial for its application in industrial settings.

The pharmacological potential of Tert-butyl 3-Hydroxy-6-azabicyclo3.2.1octane-6-carboxylate has been investigated through both computational modeling and experimental studies. Computational methods have allowed researchers to predict how this compound might interact with biological targets, providing insights into its mechanism of action. Experimental validation through in vitro and in vivo assays has further corroborated these predictions.

In vitro studies have demonstrated that derivatives of this compound can inhibit the activity of various enzymes involved in inflammatory pathways. This suggests that it may have therapeutic applications in conditions such as rheumatoid arthritis and inflammatory bowel disease. Additionally, preclinical studies have shown promising results in terms of anti-cancer activity, indicating that further exploration of this scaffold could lead to new treatments for cancer.

The chemical stability of Tert-butyl 3-Hydroxy-6-azabicyclo3.2.1octane-6-carboxylate under different conditions has also been a focus of research. Understanding how this compound behaves in various environments is essential for its practical application in pharmaceutical formulations. Stability studies have revealed that it remains intact under moderate temperatures and pH conditions, making it suitable for use in liquid or solid dosage forms.

The future prospects for Tert-butyl 3-Hydroxy-6-azabicyclo3.2.1octane-6-carboxylate are promising, with ongoing research aimed at expanding its utility across multiple therapeutic areas. Innovations in synthetic methodologies and drug delivery systems could further enhance its potential as a lead compound or intermediate in pharmaceutical development.

In conclusion, Tert-butyl 3-Hydroxy-6-azabicyclo3.2.1octane-6-carboxylate (CAS No. 1824023-63-3) represents a significant advancement in the field of organic chemistry and drug discovery。 Its unique structural features and functional groups make it a valuable asset for researchers developing novel therapeutic agents。 As our understanding of its properties continues to grow， so too will its applications across various scientific disciplines。

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)